Radiologist performance has improved since the introduction of DBT for breast cancer screening

Comparison of a 2D digital mammogram and breast tomosynthesis 3D mammography showing ability to better evaluate details in areas of dense breast tissue, rather than seeing areas of dense breast tissue overlapping, which can mimic or hide a cancer. Photo from UCSF.

Comparison of a 2D digital mammogram and breast tomosynthesis 3D mammography showing ability to better evaluate details in areas of dense breast tissue, rather than seeing areas of dense breast tissue overlapping, which can mimic or hide a cancer. Photo from UCSF.

Since being approved by the U.S. Food and Drug Administration in 2011, DBT has become the most common method for breast cancer screening, and as of September 2022, 84% of all U.S. mammography screening facilities housed DBT units.